Literature DB >> 18625677

Adenosine A2A receptor activation inhibits T helper 1 and T helper 2 cell development and effector function.

Balázs Csóka1, Leonóra Himer, Zsolt Selmeczy, E Sylvester Vizi, Pál Pacher, Catherine Ledent, Edwin A Deitch, Zoltán Spolarics, Zoltán H Németh, György Haskó.   

Abstract

Adenosine is an immunosuppressive nucleoside, and adenosine A(2A) receptors inhibit T-cell activation. We investigated the role of A(2A) receptors in regulating T helper (Th)1- and Th2-cell development and effector function. A(2A)-receptor stimulation suppressed the development of T-cell receptor (TCR) -stimulated naive T cells into both Th1 and Th2 cells, as indicated by decreased IFN-gamma production by cells developed under Th1-skewing conditions and decreased interleukin (IL) -4, IL-5, and IL-10 production by cells developed under Th2-skewing conditions. Using A(2A) receptor-deficient mice, we demonstrate that A(2A) receptor activation inhibits Th1- and Th2-cell development by decreasing the proliferation and IL-2 production of naive T cells, irrespective of whether the cells are expanded under Th1- or Th2-skewing environment. Using in vivo established Th1 and Th2 cells, we further demonstrate the nonselective nature of A(2A) receptor-mediated immunosuppressive effects, because A(2A) receptor activation decreased IFN-gamma and IL-4 secretion and mRNA level of TCR-stimulated effector Th1 and Th2 cells, respectively. A(2A) receptor mRNA expression in both Th1 and Th2 effector cells increased following TCR stimulation. In summary, these data demonstrate that A(2A) receptor activation has strong inhibitory actions during early developmental, as well as late effector, stages of Th1- and Th2-cell responses.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18625677      PMCID: PMC2537430          DOI: 10.1096/fj.08-107458

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  49 in total

1.  Adenosine acts through A2 receptors to inhibit IL-2-induced tyrosine phosphorylation of STAT5 in T lymphocytes: role of cyclic adenosine 3',5'-monophosphate and phosphatases.

Authors:  Hong Zhang; David M Conrad; Jared J Butler; Chuanli Zhao; Jonathan Blay; David W Hoskin
Journal:  J Immunol       Date:  2004-07-15       Impact factor: 5.422

2.  Adenosine affects expression of membrane molecules, cytokine and chemokine release, and the T-cell stimulatory capacity of human dendritic cells.

Authors:  Elisabeth Panther; Silvia Corinti; Marco Idzko; Yared Herouy; Matthias Napp; Andrea la Sala; Giampiero Girolomoni; Johannes Norgauer
Journal:  Blood       Date:  2002-11-21       Impact factor: 22.113

3.  Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins.

Authors:  T R Mosmann; H Cherwinski; M W Bond; M A Giedlin; R L Coffman
Journal:  J Immunol       Date:  1986-04-01       Impact factor: 5.422

4.  A3 adenosine receptor agonist potentiates natural killer cell activity.

Authors:  Arie Harish; Gil Hohana; Pnina Fishman; Oshra Arnon; Sara Bar-Yehuda
Journal:  Int J Oncol       Date:  2003-10       Impact factor: 5.650

5.  Adenosine mediates IL-13-induced inflammation and remodeling in the lung and interacts in an IL-13-adenosine amplification pathway.

Authors:  Michael R Blackburn; Chun G Lee; Hays W J Young; Zhou Zhu; Janci L Chunn; Min Jong Kang; Suman K Banerjee; Jack A Elias
Journal:  J Clin Invest       Date:  2003-08       Impact factor: 14.808

Review 6.  The case for a role for adenosine in asthma: almost convincing?

Authors:  John R Fozard
Journal:  Curr Opin Pharmacol       Date:  2003-06       Impact factor: 5.547

Review 7.  Adenosine: an endogenous regulator of innate immunity.

Authors:  György Haskó; Bruce N Cronstein
Journal:  Trends Immunol       Date:  2004-01       Impact factor: 16.687

Review 8.  Physiological control of immune response and inflammatory tissue damage by hypoxia-inducible factors and adenosine A2A receptors.

Authors:  Michail V Sitkovsky; Dmitriy Lukashev; Sergey Apasov; Hidefumi Kojima; Masahiro Koshiba; Charles Caldwell; Akio Ohta; Manfred Thiel
Journal:  Annu Rev Immunol       Date:  2004       Impact factor: 28.527

Review 9.  International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors.

Authors:  B B Fredholm; A P IJzerman; K A Jacobson; K N Klotz; J Linden
Journal:  Pharmacol Rev       Date:  2001-12       Impact factor: 18.923

10.  Enhanced mast cell activation in mice deficient in the A2b adenosine receptor.

Authors:  Xiaoyang Hua; Martina Kovarova; Kelly D Chason; MyTrang Nguyen; Beverly H Koller; Stephen L Tilley
Journal:  J Exp Med       Date:  2007-01-02       Impact factor: 14.307

View more
  72 in total

Review 1.  Regulation of lymphocyte function by adenosine.

Authors:  Joel Linden; Caglar Cekic
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-07-05       Impact factor: 8.311

2.  CD73-mediated adenosine production promotes stem cell-like properties in mouse Tc17 cells.

Authors:  Felipe Flores-Santibáñez; Dominique Fernández; Daniel Meza; Gabriela Tejón; Leonardo Vargas; Lorena Varela-Nallar; Sebastián Arredondo; Victoria Guixé; Mario Rosemblatt; María Rosa Bono; Daniela Sauma
Journal:  Immunology       Date:  2015-09-29       Impact factor: 7.397

Review 3.  The Purinergic System as a Pharmacological Target for the Treatment of Immune-Mediated Inflammatory Diseases.

Authors:  Luca Antonioli; Corrado Blandizzi; Pál Pacher; György Haskó
Journal:  Pharmacol Rev       Date:  2019-07       Impact factor: 25.468

4.  Expression of CD39 by human peripheral blood CD4+ CD25+ T cells denotes a regulatory memory phenotype.

Authors:  K M Dwyer; D Hanidziar; P Putheti; P A Hill; S Pommey; J L McRae; A Winterhalter; G Doherty; S Deaglio; M Koulmanda; W Gao; S C Robson; T B Strom
Journal:  Am J Transplant       Date:  2010-11       Impact factor: 8.086

5.  Intestinal immunopathology is associated with decreased CD73-generated adenosine during lethal infection.

Authors:  V Francois; H Shehade; V Acolty; N Preyat; P Delrée; M Moser; G Oldenhove
Journal:  Mucosal Immunol       Date:  2014-11-12       Impact factor: 7.313

6.  The immunosuppressive role of adenosine A2A receptors in ischemia reperfusion injury and islet transplantation.

Authors:  Preeti Chhabra; Joel Linden; Peter Lobo; Mark Douglas Okusa; Kenneth Lewis Brayman
Journal:  Curr Diabetes Rev       Date:  2012-11

Review 7.  Adenosine metabolism, immunity and joint health.

Authors:  György Haskó; Luca Antonioli; Bruce N Cronstein
Journal:  Biochem Pharmacol       Date:  2018-02-07       Impact factor: 5.858

Review 8.  Adenosine and adenosine receptors in the pathogenesis and treatment of rheumatic diseases.

Authors:  Bruce N Cronstein; Michail Sitkovsky
Journal:  Nat Rev Rheumatol       Date:  2016-11-10       Impact factor: 20.543

Review 9.  Adenosine signalling in diabetes mellitus--pathophysiology and therapeutic considerations.

Authors:  Luca Antonioli; Corrado Blandizzi; Balázs Csóka; Pál Pacher; György Haskó
Journal:  Nat Rev Endocrinol       Date:  2015-02-17       Impact factor: 43.330

10.  Ecto-5'-Nucleotidase (CD73) Deficiency in Mycobacterium tuberculosis-Infected Mice Enhances Neutrophil Recruitment.

Authors:  Laetitia Petit-Jentreau; Grégory Jouvion; Patricia Charles; Laleh Majlessi; Brigitte Gicquel; Ludovic Tailleux
Journal:  Infect Immun       Date:  2015-07-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.